§ Funding Round
Series U funding round for Zikani Therapeutics raising $20M in April 2018
Series U funding round for Zikani Therapeutics raising $20M in April 2018
| Investor | Firm Type | Partner |
|---|---|---|
Advent Life SciencesLEAD | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
NovartisLEAD | Organization | — |
Roche VenturesLEAD | — | — |
SR OneLEAD | — | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$70M
Top Valuation
-
Zikani Therapeutics raised $20M in a Series U round.
The round was announced on 04/01/18.
The round was led by Advent Life Sciences, Gurnet Point Capital, Novartis, Roche Ventures, SR One.
